Aldeyra drops proposed IPO shares

Aldeyra Therapeutics Inc. (Burlington, Mass.) lowered to 1.2 million the number of shares it plans to sell at $10-$12 in an IPO on NASDAQ. At the $11 midpoint, Aldeyra (formerly Aldexa Therapeutics Inc.) would raise $13.2 million and be valued at $56.9 million. Last month, the company said it planned to sell 2.3 million shares at the same price range. Aegis Capital is the sole underwriter. ...